Citadel Advisors’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88.4K Sell
33,600
-5,100
-13% -$12K ﹤0.01% 12121
2025
Q4
$73.9K Sell
38,700
-15,700
-29% -$37.2K ﹤0.01% 11843
2025
Q3
$121K Buy
+54,400
New +$131K ﹤0.01% 11702
2025
Q1
Sell
-103,100
Closed -$371K 14554
2024
Q4
$371K Buy
103,100
+84,400
+451% +$420K ﹤0.01% 9225
2024
Q3
$107K Sell
18,700
-90,300
-83% -$543K ﹤0.01% 11022
2024
Q2
$504K Sell
109,000
-45,500
-29% -$271K ﹤0.01% 8032
2024
Q1
$1.26M Sell
154,500
-58,400
-27% -$453K ﹤0.01% 6455
2023
Q4
$1.2M Buy
212,900
+197,200
+1,256% +$450K ﹤0.01% 6320
2023
Q3
$29.2K Buy
15,700
+13,800
+726% +$42.1K ﹤0.01% 12290
2023
Q2
$5.22K Sell
1,900
-600
-24% -$1.93K ﹤0.01% 13523
2023
Q1
$7.85K Sell
2,500
-1,000
-29% -$5.89K ﹤0.01% 13695
2022
Q4
$20.6K Buy
+3,500
New +$29K ﹤0.01% 13121
2022
Q2
Sell
-14,200
Closed -$344K 12958
2022
Q1
$344K Buy
+14,200
New +$345K ﹤0.01% 10277

Other funds holding CCCC